Form 4: Disc Medicine Executive Acquires Shares and Options in Recent Transaction

Jonathan Yen-Wen Yu, Chief Business Officer of Disc Medicine, Inc., reports acquisition of common stock and stock options.

Summary

• On January 10, 2024, Jonathan Yen-Wen Yu, the Chief Business Officer of Disc Medicine, Inc. (IRON), acquired 18,165 shares of common stock at $0.00.
• Yu also acquired options to purchase 27,250 shares of common stock at an exercise price of $63.90, with the options expiring on January 9, 2034.
• 25% of the options vest on January 10, 2025, and the remainder vest in 36 equal monthly installments thereafter, contingent upon continued service.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard disclosure of stock and option acquisition. The vesting schedule suggests a long-term commitment.

Positives

• The acquisition of shares and options by a key executive could be interpreted as a positive signal regarding their confidence in the company's future prospects.

Future Outlook

The vesting schedule of the options suggests a long-term commitment from the executive.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency regarding the transactions of company insiders.

Stakeholder Impact

• The acquisition of shares and options by a key executive could positively influence shareholder sentiment.

Key Dates